Search results
4 kwi 2012 · In this paper, we will provide a review of the prognostic factors of malignant ascites, the pathophysiology of ascites formation, current diagnostic modalities, traditional therapeutic measures and newer therapies, including current medical and surgical treatment options.
- Clinical practice guideline for the treatment of malignant ascites ...
The guidelines summarize the general aspect of the treatment...
- Malignant ascites in pancreatic cancer: Pathophysiology, diagnosis ...
This review aims to summarize the current understanding of...
- Clinical practice guideline for the treatment of malignant ascites ...
Two main reasons cause ascites in patients with cancer. First, cancer can spread to the lining of the organs—the peritoneum—and make it leaky, causing malignant ascites. Second, cancer can spread to the liver and cause increased pressure in the liver.
12 wrz 2023 · Malignant ascites (MA) is defined by the presence of tumor cells within the ascitic fluid. It does not only cause substantial morbidity, but is also associated with impaired survival.
20 lis 2021 · The guidelines summarize the general aspect of the treatment of malignant ascites and statements with recommendation strengths, evidence levels, agreement rates and future perspective for four raised clinical questions.
16 mar 2023 · This review aims to summarize the current understanding of malignant ascites in pancreatic cancer and the recent advances in the molecular characterization of malignant ascites fluid from patients with pancreatic cancer including analysis of soluble molecules and extracellular vesicles.
31 mar 2012 · Malignant ascites (MA) is a pathological condition due to a variety of primary abdominal and extra-abdominal neoplasms. It is a primary cause of morbidity and presents many difficulties and treatment challenges.
Malignant ascites is a manifestation of end stage events in a variety of cancers and is associated with significant morbidity. It accounts for about 10% of all cases of ascites and usually caused by ovarian, endometrial, breast, oesophageal, gastric, colorectal, lung, pancreatic, hepatobiliary and primary peritoneal carcinomas [1–3].
